Time-Restricted Eating for Type 2 Diabetes

This study is looking at whether Time-Restricted Eating (TRE) can help people with type 2 diabetes manage their blood sugar and heart health. TRE involves eating all your meals within an 8-10 hour window each day. You could join if you are 18-75 years old, have type 2 diabetes with an A1c (a measure of average blood sugar) between 6.5% and 9.0%, and use a smartphone. The study will compare people who continue their usual doctor's care with those who also try TRE. Success will be measured by changes in your A1c levels after 3 months. The current status of this study is unclear, but it plans to enroll 60 participants.

Study design
This is a randomized clinical trial, meaning participants are assigned to one of two groups by chance. It plans to enroll 60 participants.
What's involved
The intervention will last for 12 weeks, with clinic visits, virtual consultations, and monitoring through sensors and a smartphone app. There will be a follow-up assessment at 6 months.
Compensation
Not stated in the trial record.
Follow-up
Participants will have a follow-up assessment at 6 months after the 12-week intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05365529

Time-Restricted Eating for Type II Diabetes: TRE-T2D

Active, Not Recruiting
NAAges 18–75InterventionalTreatment
University of California, San Diego
~60 participants
Updated 2026-06-11 on ClinicalTrials.gov
What's tested:Time-Restricted EatingStandard of Care

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Glycemic regulation assessed by HbA1c
Measured over Baseline and 3 months
Diabetes Mellitus, Type 2
Time Restricted Feeding
Diabetes type2
1 sites across 1 states
California1
  • Pam Taub, MD · PRINCIPAL_INVESTIGATOR · Professor of Medicine

This trial hasn't published a contact. View it on ClinicalTrials.gov

  • Glycemic regulation assessed by HbA1cBaseline and 3 months

    Change in blood glucose assessed via hemoglobin A1c.